A de novo missense mutation in PPP2R5D alters dopamine pathways and morphology of iPSC-derived midbrain neurons
Stem Cells · 2025
DOI: 10.1093/stmcls/sxae068 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cells, 2025. Verfasst von Jasmine L Carter und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Interventional Genetics, University of California, Davis, Sacramento, CA 95817, United States. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Mesencephalon, Mutation, Missense, Dopamine. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIMH NIH HHS, Learning Memory and Plasticity.
Abstract (Originalsprache)
Induced pluripotent stem cell (iPSC) models of neurodevelopmental disorders (NDDs) have promoted an understanding of commonalities and differences within or across patient populations by revealing the underlying molecular and cellular mechanisms contributing to disease pathology. Here, we focus on developing a human model for PPP2R5D-related NDD, called Jordan syndrome, which has been linked to Early-Onset Parkinson’s Disease (EOPD). Here we sought to understand the underlying molecular and cellular phenotypes across multiple cell states and neuronal subtypes in order to gain insight into Jordan syndrome pathology. Our work revealed that iPSC-derived midbrain neurons from Jordan syndrome patients display significant differences in dopamine-associated pathways and neuronal architecture. We then evaluated a CRISPR-based approach for editing heterozygous dominant G-to-A mutations at the transcript level in patient-derived neural stem cells. Our findings show that site-directed RNA editing is influenced by sgRNA length and cell type. These studies support the potential for a CRISPR RNA editor system to selectively edit mutant transcripts harboring G-to-A mutations in neural stem cells while providing an alternative editing technology for those suffering from NDDs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Interventional Genetics, University of California, Davis, Sacramento, CA 95817, United States.
- MIND Institute, University of California, Davis, Sacramento, CA 95817, United States.
- Stem Cell Program and Gene Therapy Center, University of California, Davis, Sacramento, CA 95817, United States.
- Institute for Regenerative Cures, University of California, Davis, Sacramento, CA 95817, United States.
- Department of Neurology, University of California Davis Health Systems, Sacramento, CA, United States.
- Center for Neuroscience, University of California Davis, Sacramento, CA 95817, United States.
ORCID-Profile: Julian A N M Halmai, Kyle D Fink
Förderung
- NIGMS NIH HHS
- NIMH NIH HHS
- Learning Memory and Plasticity
Zitieren
APA
Carter, J. L., Halmai, J. A. N. M., Waldo, J. J., Vij, P. A., Anguiano, M., Villegas, I. J., Du, Y. X., Nolta, J., & Fink, K. D. (2025). A de novo missense mutation in PPP2R5D alters dopamine pathways and morphology of iPSC-derived midbrain neurons. Stem Cells. https://doi.org/10.1093/stmcls/sxae068
Vancouver
Carter JL, Halmai JANM, Waldo JJ, Vij PA, Anguiano M, Villegas IJ, et al. A de novo missense mutation in PPP2R5D alters dopamine pathways and morphology of iPSC-derived midbrain neurons. Stem Cells. 2025. doi:10.1093/stmcls/sxae068
BibTeX
@article{Carter2025,
author = {Carter, Jasmine L and Halmai, Julian A N M and Waldo, Jennifer J and Vij, Paula A and Anguiano, Maribel and Villegas, Isaac J and Du, Yu Xin and Nolta, Jan and Fink, Kyle D},
title = {A de novo missense mutation in PPP2R5D alters dopamine pathways and morphology of iPSC-derived midbrain neurons},
journal = {Stem Cells},
year = {2025},
doi = {10.1093/stmcls/sxae068}
}
EUVIMED